Latest Articles
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
Biontech prepares FDA application after strong phase II results in endometrial cancer medwatch.com
Published: April 13, 2026, 12:14 p.m.
Endometrial cancer trial: BioNTech (Nasdaq: BNTX) ADC hits Phase 2 goal - Stock Titan
Endometrial cancer trial: BioNTech (Nasdaq: BNTX) ADC hits Phase 2 goal Stock Titan
Published: April 13, 2026, 11:55 a.m.
Briefcase Parties... - standardmedia.co.ke
Briefcase Parties... standardmedia.co.ke
Published: April 13, 2026, 11:55 a.m.
A Look At BioNTech (BNTX) Valuation After Positive Phase 2 HER2 Endometrial Cancer Data - Sahm
A Look At BioNTech (BNTX) Valuation After Positive Phase 2 HER2 Endometrial Cancer Data Sahm
Published: April 13, 2026, 10:35 a.m.
China launches AI-powered digital doctor platform for Parkinson's disease - standardmedia.co.ke
China launches AI-powered digital doctor platform for Parkinson's disease standardmedia.co.ke
Published: April 13, 2026, 9:19 a.m.
Not a death sentence: I have lived with sickle cell disease for 61 years - standardmedia.co.ke
Not a death sentence: I have lived with sickle cell disease for 61 years standardmedia.co.ke
Published: April 13, 2026, 3 a.m.
The debilitating disease most women have never heard of - bodyandsoul.com.au
The debilitating disease most women have never heard of bodyandsoul.com.au
Published: April 12, 2026, 8:34 p.m.
A Look At BioNTech (BNTX) Valuation After Positive Phase 2 HER2 Endometrial Cancer Data - simplywall.st
A Look At BioNTech (BNTX) Valuation After Positive Phase 2 HER2 Endometrial Cancer Data simplywall.st
Published: April 12, 2026, 7:29 p.m.
Strong early data prompts GSK to plan five Phase 3 studies for gynecological cancer ADC - Endpoints News
Strong early data prompts GSK to plan five Phase 3 studies for gynecological cancer ADC Endpoints News
Published: April 12, 2026, 2:10 p.m.
GSK CEO's 'scientific courage' propels plans for medley of phase 3 trials for Hansoh-partnered ADC - Fierce Biotech
GSK CEO's 'scientific courage' propels plans for medley of phase 3 trials for Hansoh-partnered ADC Fierce Biotech
Published: April 12, 2026, 2:10 p.m.
Link copied to clipboard!